Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes

Journal of Epidemiology and Community Health

Volumn 62, Issue 9, 2008, Pages 804-810

  Bruneau, Julie ^a   Daniel, M ^a   Kestens, Y ^a,b   Zang, G ^a   Genereux M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Gouvernement du Quebec   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY; GIS; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; REGRESSION ANALYSIS;

ARTICLE; BLOOD SAMPLING; CANADA; COMMUNITY LIVING; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; HEALTH BEHAVIOR; HEALTH CARE AVAILABILITY; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHARMACY; PREVENTIVE HEALTH SERVICE; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; SYRINGE;

EID: 50149119032     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2007.064154     Document Type: Article

References (31)

1. Des Jarlais DC, Marmor M. Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health 2000;90:352-9.
2. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV serroconversion among injecting drug users. AIDS 2001;15:1329-41.
3. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programs: current issues and future prospects. Soc Sci Med 2000;51:1771-82.
4. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programs for prevention of HIV infection. Lancet 1997; 349:1797-800.
5. Jones TS, Coffin PO. Preventing blond-bome infections through pharmacy syringe sales and safe community syringe disposal. J Am Pharm Assoc 2002;42:S6-9.
6. van Ameijden EJC, van den Hoek JAR, Coutinho RA. Injecting risk behaviour among drug users in Amsterdam from 1986 to 1992, and its relation to AIDS-prevention programmes. Am J Public Health 1994; 84:275-81.
7. Kral AH, Anderson R, Flynn NM, et al. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. J Acquir Immune Defic Syndr 2004; 37:1307-12.
8. Strathdee SA, Patrick OM, Archibald CP, et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction 1997;92:1339-47.
9. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol 1997;146:994-1002.
10. Hagan H, McGough JP, Thiede H, et al. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999;149:203-13.
11. Schachter MT, Strathdee SA, Comelisse PG, et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS 1999; 13:F45-51.
12. Hahn JA, Vranizan KM, Moss AR. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. J Acquir Immune Defic Syndr 1997;15:157-64.
13. Marmor M, Shore RE, Titus S. et al. Drug injection rates and needle-exchange use in New York City, 1991-1996. J Urban Health 2000;77:359-68.
14. Vlahov D. The role of epidemiology in needle exchange programs. Am J Public Health 2000;90:1390-2.
15. Bluthenthal RN, Malik MR, Grau LE, et al. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction 2004;99:1136-46.
16. Heimer R, Clair S, Tang W, et al. Effects of increasing syringe availability an syringe-exchange use and HIV risk: Connecticut, 1990-2001. J Urban Health 2002;79:556-70.
17. Tyndall MW, Bruneau J, Brogly S, et al. Satellite needle distribution among injection drug users: policy and practice in two Canadian cities. J Acquir Immune Defic Syndr 2002; 31:98-105.
18. Hue D, Bailey SL, Hershow RC, et al. Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Educ Prev 2005;17:170-84.
19. Lorvick J, Bluthenthal RN, Scott A, et al. Secondary syringe exchange among users of 23 California syringe exchange programs. Subst Use Misuse 2006;41:865-82.
20. Rockwell R, Des Jarlais DC, Friedman SR, et al. Geographic proximity, policy and utilization af syringe exchange programmes. AIDS Care 1999;11:437-42.
21. Hutchinson SJ, Taylor A, Goldberg DJ, et al. Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-bome viruses. Addiction 2000; 95:931-40.
22. Sacteur Vigie at Protection, Direction do la Santé Publique, Agence de la santé et des services sociaux do Muntréal. Appel à la vigilance: recrudescence d'infections par le VIH et le VHC chez les utilisateurs de drogues injectables de Montréal. Août 2006. Available from: http://www.santepub-mtl.qc.ca/Mi/vigilance/31082006.html (Accessed 2 October 2006)
23. Bruneau J, Lamothe F, Soto J, et al. Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ 2001;164:767-73.
24. Bow CJ, Waters NM, Faris PD, et al. Accuracy of city postal code coordinates as a proxy for location of residence. Int J Health Geogr 2004;3:5.
25. Hanchette CL, Gibbs DA, Gilliam A, et al. A national, geographic database of CDC-funded HIV prevention services: development challenges and potential applications. Int J Health Geogr 2005; 4:28.
26. Service de lutte aux ITSS, Institut National de Santé Publique, Ministère de la Santé et des Services Sociaux, Ouébec, Canada. Liste officielle des centres d'accès aux seringues du Québec, 2004-2005. 2005:72p.
27. Noel L, Cloutier R. Statistiques sur les services aux programmes de prevention du VIH at des Hépatites B et C offerts aux usagers do drogues par injection du Québec. Ministère Santé at Services Sociaux, Service de Lutte aux ITSS, Institut National de Santé Publique, Gouvernement du Québec, Canada. 2005; 23.
28. Buchanan D, Shaw S, Teng W, et al. Neighborhood differences in patterns of syringe access, use, and discard among injection drug users: implications for HIV outreach and prevention education. J Urban Health 2003;80:438-54.
29. Welton A, Adelberger K, Patterson K, et al. Optimal placement of syringe-exchange programs. J Urban Health 2004; 81:268-77.
30. Latkin CA, Williams CT, Wang J, et al. Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach. Health Psychol 2005;24:96-100.
31. Comité permanent do lutte à la toxicomanie. Le point sur la situation de la toxicomanie au Québec: an l'an 2000. Québec, Canada. 2001. Available from: http://publications.msss.gouv.qc.ca/biblio/CPLT/publications/0900pt.pdf (Accessed 6 November 2006)